Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
A nuclear receptor, peroxisome proliferator-activated receptor gamma (PPARgamma), is a ligand-dependent transcription factor involved in glucose homeostasis and adipocyte differentiation. PPARgamma is the molecular target of various natural and synthetic molecules, including anti-diabetic agents such as rosiglitazone. Amide hydrogen/deuterium-exchange (H/D-Ex), coupled with proteolysis and mass spectrometry, was applied to study the dynamics of the PPARgamma ligand binding domain (LBD) with or without molecules that modulate PPARgamma activity. The H/D-Ex patterns of ligand-free PPARgamma LBD show that the ligand binding pocket of LBD is significantly more dynamic than the rest of the LBD. Presumably, the binding pocket is intrinsically disordered in order to accommodate different ligands. The presence of two full agonists (rosiglitazone and GW1929), a partial agonist (nTZDpa), and a covalent antagonist (GW9662), changed the dynamics/conformation of PPARgamma LBD and slowed the H/D exchange rate in various regions of the protein. The full agonists slowed the H/D exchange more globally and to a greater extent than the partial agonist or the antagonist, indicating that the full agonist stabilizes the PPARgamma LBD more than the partial agonist or the antagonist. One interesting observation is that the two full agonists significantly stabilized helix 12 while the partial agonist and the antagonist did not perturb the H/D exchange of this region. The results showed that the change in protein dynamics induced by ligand binding may be an important factor for the activation of genes and that H/D-Ex is a useful method for analyzing the biological activity of drug leads.
Hamuro
Yoshitomo
Y
ExSAR Corp., Monmouth Junction, New Jersey 08852, USA. yhamuro@exsar.com
Coales
Stephen J
SJ
Morrow
Jeffrey A
JA
Molnar
Kathleen S
KS
Tuske
Steven J
SJ
Southern
Mark R
MR
Griffin
Patrick R
PR
D000577:Amides / Q000737:chemistry; D000595:Amino Acid Sequence; D000813:Anilides / Q000494:pharmacology; D001577:Benzophenones / Q000494:pharmacology; D001665:Binding Sites; D041961:Deuterium Exchange Measurement; D007211:Indoles / Q000494:pharmacology; D008024:Ligands; D013058:Mass Spectrometry; D008958:Models, Molecular; D047495:PPAR gamma / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry*; D010434:Pepsin A / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism; D011487:Protein Conformation / Q000187:drug effects; D017434:Protein Structure, Tertiary / Q000187:drug effects*; D000077154:Rosiglitazone; D013440:Sulfides / Q000494:pharmacology; D045162:Thiazolidinediones / Q000494:pharmacology; D014443:Tyrosine / Q000031:analogs & derivatives / Q000494:pharmacology
C457499:2-chloro-5-nitrobenzanilide; C479635:5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid; D000577:Amides; D000813:Anilides; D001577:Benzophenones; D007211:Indoles; D008024:Ligands; D047495:PPAR gamma; D010446:Peptide Fragments; D013440:Sulfides; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D014443:Tyrosine; D010434:Pepsin A; C120099:GW 1929